Between the Belly and the Brain: Distorted Gut-brain Crosstalk in Early-life Adversity
BellyBrain
1 other identifier
observational
50
1 country
1
Brief Summary
The goal of this observational study is to learn about the effects of early-life adversity (ELA) on the composition of children's microbiome and on their psychosocial functioning. The main questions it aims to answer are:
- Do children who have experienced ELA have lower gut microbial diversity and/or an altered gut microbial composition?
- Do these microbiome alterations correlate with adverse neurodevelopmental outcomes, including increased levels of stress, social and/or affective problems?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 3, 2025
CompletedFirst Posted
Study publicly available on registry
April 10, 2025
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedApril 10, 2025
April 1, 2025
11 months
April 3, 2025
April 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Global mental wellbeing
KIDSCREEN-10 total score
Assessment at enrollment
Microbiomial diversity
Gut microbiomial beta-diversity, based on UniFrac and Bray-Curtis distance index
Assessment based on single stool sample, within 4 weeks after enrollment
Secondary Outcomes (5)
Post-traumatic stress symptoms
Assessment at enrollment
Anxiety and depression symptoms
Assessment at enrollment
Firmicutes/Bacteroidetes ratio
Assessment based on single stool sample, within 4 weeks after enrollment
Gut microbiomial composition
Assessment based on single stool sample, within 4 weeks after enrollment
Short-chain fatty acid metabolites
Assessment based on single stool sample, within 4 weeks after enrollment
Interventions
Completion of questionnaires: * FFQ (Food Frequency Questionnaire) - completed by child * KIDSCREEN-10 - completed by child * CRIES-13 (Child Revised Impact of Events Scale) - completed by parents/guardian and child * CTES (Childhood Trust Events Survey) - completed by parents/guardian * RCADS-25 (Revised Children's Anxiety and Depression Scale) - completed by parents/guardian and child Child psychiatric screening using SCID-5-Junior - semi-structured interview conducted with child and parent(s)/guardian Faecal sample analysis: * Beta-diversity (UniFrac and Bray-Curtis distance index) * Firmicutes/Bacteroidetes ratio * Abundance of Prevotella, Lactobacillaceae, Bifidobacteriacae and Lachnospiraceae * Short-chain fatty acid metabolites
Eligibility Criteria
Primary school-aged children (6 to 13 years of age) who have been referred to the UZ Brussel child and adolescent psychiatry department
You may qualify if:
- Primary school-aged children (6 to 13 years of age) who have experienced at least one early-life traumatic event, based on the Childhood Trust Events Survey (CTES) questionnaire
- The child and at least one of his/her parents (or guardian) speak Dutch sufficiently well to complete all of the questionnaires and the semi-structured child psychiatric interview (SCID-5-Junior)
You may not qualify if:
- any chronic disorders or diseases known to affect the gut micobiome
- inablity to complete questionnaires and/or semi-structured interview because of linguistic and/or cognitive barrier
- congenital or acquired immunodeficiencies
- use of medication(s) that affect gastrointestinal function (e.g., antibiotics) within the last 6 weeks, or laxatives within the last 4 weeks, or probiotic or prebiotic supplements within the last 4 weeks
- current involvement in another clinical or food study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UZ Brussel
Jette, Brussels Capital, 1090, Belgium
Biospecimen
Faecal sample
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 3, 2025
First Posted
April 10, 2025
Study Start
May 1, 2025
Primary Completion
April 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
April 10, 2025
Record last verified: 2025-04